Capital Health Medical Center – Hopewell is now a NCI Community Oncology Research Program (NCORP) affiliate site of the Atlantic Health Cancer Consortium (AHCC). As a participating site, Capital Health Cancer Center will now offer residents in the greater Mercer and Bucks County region access to new and innovative NCI-sponsored clinical trials in the cancer prevention and control, screening, care delivery, and treatment areas.
“The vision for our Cancer Center is clear,” said Al Maghazehe, president and CEO of Capital Health, “To deliver exceptional care for our patients in a convenient location, with the clinical and support services they need and the research to support their fight and the advancement of care. Our participation in NCORP brings more opportunities to our patients, who are at the heart of everything we do.”
“With the NCORP site designation, our Cancer Center will provide patients access to cancer clinical trials and cancer care delivery studies that are available at top institutions around the nation,” said Dr. Cataldo Doria, medical director of Capital Health Cancer Center. “We look forward to contributing to NCORP’s national network of research that focuses on cancer prevention, screening, and treatment, especially in regard to how it affects access to care among underserved populations.”
“Academic medical centers play an important part in cancer research, but most cancer care is provided in local communities,” said Dr. Doria. “By expanding research outside academic settings as an AHCC NCORP site, we will provide access to a larger patient population that is more diverse and better reflects the complexity of cancer care.”
As part of AHCC NCORP, Capital Health Cancer Center’s team of providers and researchers will help patients gain access to clinical trials across a broad range of cancer care benchmarks, including symptom management, prevention, screening, surveillance, care delivery and quality of life. The NCORP network’s diversity in patient age, race, and geographic location, provides a natural laboratory for developing improved strategies for cancer prevention, more efficient cancer trials, and a better balance between the risks and benefits of interventions.
“On behalf of the entire organization, I am excited to welcome Capital Health Medical Center – Hopewell to Atlantic Health Cancer Consortium Community Oncology Research Program (AHCC CORP), the only New Jersey-based NCI Community Oncology Research Program (NCORP),” said Dr. Eric Whitman, principal investigator at AHCC CORP and medical director of Atlantic Health System Cancer Care. “Together we will continue to advance the science of cancer care and shine new lights on cancer journey pathways for our patients.”
To help connect patients to advanced care options, research staff at Capital Health Cancer Center will select trials from the NCORP research portfolio that may benefit the Center’s patient population. Appropriate studies are then presented to oncology physician teams to determine if they are good fits for specific patients. When a match is made, a primary investigator is appointed, and Capital Health research staff open the trial for Capital Health Cancer Center patients.
To access more business news, visit NJB News Now.Related Articles: